Advanced search
Publication Cover
Journal of Parkinsonism and Restless Legs Syndrome Volume 6, 2016 - Issue
Journal homepage
776
Views
17
CrossRef citations to date
0
Altmetric
Review

Drug-induced parkinsonism: diagnosis and management

Pierre J Blanchet1 Department of Stomatology, Faculty of Dental Medicine, University of Montreal;2 Andre-Barbeau Movement Disorders Unit, University of Montreal Hospital Center (CHU Montreal);3 Montreal Mental Health University Institute, Montreal, QC, CanadaCorrespondence[email protected]
&
Veronika Kivenko1 Department of Stomatology, Faculty of Dental Medicine, University of Montreal;2 Andre-Barbeau Movement Disorders Unit, University of Montreal Hospital Center (CHU Montreal);3 Montreal Mental Health University Institute, Montreal, QC, Canada
Pages 83-91 | Published online: 23 Sep 2016

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Matthew Feldman, Sarah Marmol & Jason Margolesky. (2022) Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic. Therapeutics and Clinical Risk Management 18, pages 1129-1142.
Read now
Hyungtae Kim & Hae Sun Suh. (2020) Effects of a Safety Letter on Metoclopramide Use in Korea: An Interrupted Time-Series Analysis. Risk Management and Healthcare Policy 13, pages 1335-1341.
Read now
Jason Margolesky. (2019) Approaching drug-induced parkinsonism from a neurohospitalist perspective. Expert Review of Neurotherapeutics 19:2, pages 93-95.
Read now

Articles from other publishers (14)

Siin Kim & Hae Sun Suh. (2023) Treatment Changes and Prognoses in Patients with Incident Drug-Induced Parkinsonism Using a Korean Nationwide Healthcare Claims Database. Journal of Clinical Medicine 12:8, pages 2860.
Crossref
American Psychiatric Association. 2022. Diagnostic and Statistical Manual of Mental Disorders. Diagnostic and Statistical Manual of Mental Disorders.
Megan R. Undeberg, Kimberly C. McKeirnan & David Easley. (2022) Respecting the Patient’s Choice: A Case of Possible Drug-Induced Parkinsonism. Pharmacy 10:1, pages 10.
Crossref
Hilde M Geurts, Goldie A McQuaid, Sander Begeer & Gregory L Wallace. (2021) Self-reported parkinsonism features in older autistic adults: A descriptive study. Autism 26:1, pages 217-229.
Crossref
Mahan Shafie, Mahsa Mayeli, Samira Saeidi, Zahra Mirsepassi, Mehrshad Abbasi, Melika Shafeghat & Vajiheh Aghamollaii. (2022) The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease. Clinical Parkinsonism & Related Disorders 6, pages 100130.
Crossref
Sharadha Wisidagama, Abiram Selladurai, Peter Wu, Marco Isetta & Jordi Serra-Mestres. (2021) Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review. Medicines 8:6, pages 24.
Crossref
Kenichiro Sato, Tatsuo Mano, Atsushi Iwata & Tatsushi Toda. (2021) Disproportionality by sex in the prescription of drugs capable of inducing parkinsonism for the elderly: A survey using statistics of Japanese national health claims from 2014 to 2017. Neurology and Clinical Neuroscience 9:3, pages 211-217.
Crossref
Samir KashyapRita CeponieneParas SavlaJacob BernsteinHammad GhanchiAjay Ananda. (2020) Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement. Surgical Neurology International 11, pages 444.
Crossref
Meenakshi Dhanawat, Dinesh K. Mehta, Sumeet Gupta & Rina Das. (2020) Understanding the Pathogenesis Involved in Parkinson’s Disease and Potential Therapeutic Treatment Strategies. Central Nervous System Agents in Medicinal Chemistry 20:2, pages 88-102.
Crossref
Abilash Muralidharan, Jawaria Rahman, Dipanjan Banerjee, Abdul Rub Hakim Mohammed & Bilal Haider Malik. (2020) Parkinsonism: A Rare Adverse Effect of Valproic Acid. Cureus.
Crossref
Katrin Druschky, Stefan Bleich, Renate Grohmann, Rolf R. Engel, Sermin Toto, Alexandra Neyazi, Barbara Däubl & Susanne Stübner. (2019) Severe parkinsonism under treatment with antipsychotic drugs. European Archives of Psychiatry and Clinical Neuroscience 270:1, pages 35-47.
Crossref
Michael P. Caligiuri, Hans-Leo Teulings, Charles E. Dean & James B. Lohr. (2019) The nature of bradykinesia in schizophrenia treated with antipsychotics. Psychiatry Research 273, pages 537-543.
Crossref
Kristen M. Ward & Leslie Citrome. (2018) Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management. Neurology and Therapy 7:2, pages 233-248.
Crossref
Esther Letícia Amorim Ribeiro, Tácio de Mendonça Lima, Marcio Eduardo Bergamini Vieira, Sílvia Storpirtis & Patricia Melo Aguiar. (2018) Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews. European Journal of Clinical Pharmacology 74:10, pages 1215-1233.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.